Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer - PubMed
4 hours ago
- #Retraction
- #BCG
- #Bladder Cancer
- Retraction of the article 'Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer'.
- Original article published in Nature Communications in 2022, retracted in 2026.
- The retraction note is associated with PMID: 41872197 and PMCID: PMC13009469.
- DOI for the retraction note: 10.1038/s41467-026-70972-5.